Skip to content
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of […]
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025 Read More »
January brought important changes for the roughly 53 million seniors enrolled in Medicare prescription drug plans. Some of these changes are automatic, while others
Medicare Part D plans are changing for 2025 – here’s what patients need to know Read More »
Pharmacy benefit managers (PBMs) make billions in profit while driving up the price of prescription drugs with markups that can exceed 1,000%, according to
FTC’s second report on PBMs blasts drug price markups of 1,000% Read More »
As science progresses, we need parallel progress in making breakthrough treatments widely available, BIO President & CEO John F. Crowley said at a Jan.
BIO CEO urges innovation in access at White House CGT forum Read More »
The increased interest in JPM Week this year is an indication of an improved dealmaking environment for biotech, according to experts for the Biotechnology
Buzz around JPM Week partnering bodes well for biotech dealmaking, BIO says Read More »
A dispute panel ruled that Mexico’s planned ban on imports of biotech corn is “not based on relevant scientific principles” and would violate the U.S.-Mexico-Canada
USMCA dispute panel halts Mexico’s ban on biotech corn Read More »
Federal officials said they withdrew plans for new regulation of genetically engineered (GE) crops on U.S. wildlife refuges due to the outcry by numerous
How BIO’s comments affected regulations on genetically engineered crops Read More »
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand the issue clearly. In
Combatting misinformation on biotechnology in food Read More »
The 10-year-old girl was cheerful and upbeat as she spoke to a group of strangers online, but she was also disarmingly clear-eyed about the
Children with rare diseases advocate for legislation in online panel Read More »
HIV is not the death sentence that it was decades ago. Yet, there is still much work to be done in the HIV advocacy
How to break down barriers in HIV care Read More »
